Regeneron Pharmaceuticals, Inc. REGN on Tuesday announced five-year follow-up results on overall survival (OS) from the Phase 3 EMPOWER-Lung 3 trial of Libtayo (cemiplimab) plus platinum-based ...

The U.S. Food and Drug Administration (FDA) on Thursday granted Breakthrough Therapy designation to Eli Lilly and Co.’s LLY olomorasib, in combination with Merck & Co. Inc.’s MRK anti-PD-1 therapy ...

Rivals routinely cycles between different limited-time game modes, and the latest of these is the Hardcore Parkour mode. Hardcore Parkour is all about racing an opponent in an obstacle course, where ...

Roomba Max 705 Combo Provides heated mopping, 175x more suction power and first-of-its-kind cover protecting carpets from wet messes BEDFORD, Mass., July 22, 2025 /PRNewswire/ -- iRobot Corp. (NASDAQ: ...

Recent phase 2 data support combination treatment with samuraciclib for those with HR+ advanced breast cancer following prior CDK4/6 inhibitor therapy. Results from two phase 2 trials support ...

Peluntamig targets DLL3 and CD47, potentially enhancing immune recognition and attack on cancer cells. The SKYBRIDGE study is a phase 1/2 trial assessing peluntamig's safety and efficacy in ...

Learn how to install Roblox shaders using ReShade with this step-by-step tutorial for enhanced graphics and improved gaming experience.

Feb. 13, 2025 -- The FDA has approved a new three-drug combination to treat certain types of an aggressive blood cancer called large B-cell lymphoma (LBCL). LBCL is a fast-growing cancer of B cells, a ...

More for You Barack Obama responds to Donald Trump's Russia "treason" threats US military releases footage it says shows live grenade being dropped from drone In-N-Out owner responds to backlash over ...

Isonade is one of the Mythical fish, which means that it is the rarest in Fisch. Here's everything you need to know to catch this rare fish. This item is vital for diving, as it significantly ...

The phase 1/2 SAINT study is currently investigating intravenous trabectedin plus ipilimumab and nivolumab in the first line for advanced soft tissue sarcoma. The study investigators from City of Hope ...

BARCELONA, Spain — Adding retifanlimab, an anti–programmed cell death 1 (PD-1) monoclonal antibody, to carboplatin plus paclitaxel in inoperable locally recurrent or metastatic squamous cell carcinoma ...